(Q40707796)

22 September 2017

title

Ovarian cancer: A solid tumor with evidence of normal cellular immune function but abnormal B cell function (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

9 March 2023

1 reference

cell-mediated immunity

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312015

9 March 2023

1 reference

G. L. Mandell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312015

9 March 2023

R. I. Fisher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312015

9 March 2023

F. Bostick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312015

9 March 2023

R. C. Young

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312015

9 March 2023

language of work or name

English

0 references

publication date

1 April 1979

1 reference

full work available at URL

22 September 2017

https://api.elsevier.com/content/article/PII:0002934379911720?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

https://api.elsevier.com/content/article/PII:0002934379911720?httpAccept=text/plain

9 March 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

American Journal of Medicine

9 March 2023

published in

1 reference

22 September 2017

volume

66

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

621-624

1 reference

Overview of tumor immunology in gynecologic oncology

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Demonstration of cell-mediated immunity to human neoplasms of various histological types

9 March 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Possibilities and Problems of Immunologic Intervention in Cancer

9 March 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Immunological Aspects of Neoplasia: A Rational Basis for Immunotherapy

9 March 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Immunologic alterations in bronchogenic cancer. Sequential study

9 March 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Cell-mediated immunity in patients with ovarian carcinoma.

9 March 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Cellular immunologic responsiveness to extracts of ovarian epithelial tumors

9 March 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Isolation of tumor-specific antibodies from effusions of ovarian carcinomas

9 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

In vitro activation of human T and B lymphocytes by pokeweed mitogen

9 March 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

A buffered chromic chloride method of attaching antigens to red cells: use in haemagglutination

9 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

Lymphocyte response to autologous tumor antigen(S) and phytohemagglutinin in ovarian cancer patients

9 March 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91172-0

9 March 2023

Identifiers

1 reference

22 September 2017

1 reference